These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Activity of fluconazole against Candida albicans isolates from HIV+ patients in a digestive candidosis turkey model. Reynes J; Mallie M; Ravisse P; Bastide JM J Med Vet Mycol; 1992; 30(5):363-7. PubMed ID: 1469537 [TBL] [Abstract][Full Text] [Related]
3. [Oro-esophageal candidiasis resistant to fluconazole in patients with AIDS]. Diz P; Ocampo A; Miralles C; Otero I; Iglesias I; Martínez C Enferm Infecc Microbiol Clin; 1993 Jan; 11(1):36-9. PubMed ID: 8461371 [TBL] [Abstract][Full Text] [Related]
4. [Oropharyngeal candidiasis resistant to fluconazole in patients infected by HIV]. Drobacheff C; Manteaux A; Millon L; Reboux G; Barale T; Laurent R Ann Dermatol Venereol; 1996; 123(2):85-9. PubMed ID: 8761757 [TBL] [Abstract][Full Text] [Related]
5. Evolution of antifungal susceptibility among Candida species isolates recovered from human immunodeficiency virus-infected women receiving fluconazole prophylaxis. Vazquez JA; Peng G; Sobel JD; Steele-Moore L; Schuman P; Holloway W; Neaton JD Clin Infect Dis; 2001 Oct; 33(7):1069-75. PubMed ID: 11528582 [TBL] [Abstract][Full Text] [Related]
6. The evolution of Candida species and fluconazole susceptibility among oral and vaginal isolates recovered from human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women. Sobel JD; Ohmit SE; Schuman P; Klein RS; Mayer K; Duerr A; Vazquez JA; Rampalo A; J Infect Dis; 2001 Jan; 183(2):286-93. PubMed ID: 11204125 [TBL] [Abstract][Full Text] [Related]
7. [Antifungal susceptibility for Candida albicans isolated from AIDS patients with oropharyngeal and esophageal candidiasis: experience with Etest]. Tapia C; González P; Pereira A; Pérez J; Noriega LM; Palavecino E Rev Med Chil; 2003 May; 131(5):515-9. PubMed ID: 12879812 [TBL] [Abstract][Full Text] [Related]
8. Increasing resistance of Candida albicans to fluconazole. Oldfield EC Am J Gastroenterol; 1995 Jul; 90(7):1182. PubMed ID: 7611229 [No Abstract] [Full Text] [Related]
9. Prevention of symptomatic recurrences of esophageal candidiasis in AIDS patients after the first episode: a prospective open study. Parente F; Ardizzone S; Cernuschi M; Antinori S; Esposito R; Moroni M; Lazzarin A; Bianchi Porro G Am J Gastroenterol; 1994 Mar; 89(3):416-20. PubMed ID: 8122656 [TBL] [Abstract][Full Text] [Related]
10. Fluconazole-resistant Candida in AIDS patients. Report of two cases. Heinic GS; Stevens DA; Greenspan D; MacPhail LA; Dodd CL; Stringari S; Strull WM; Hollander H Oral Surg Oral Med Oral Pathol; 1993 Dec; 76(6):711-5. PubMed ID: 8284074 [TBL] [Abstract][Full Text] [Related]
12. Assessment of therapeutic response of oropharyngeal and esophageal candidiasis in AIDS with use of a new clinical scoring system: studies with D0870. Hood SV; Hollis S; Percy M; Atkinson G; Williams K; Denning DW Clin Infect Dis; 1999 Mar; 28(3):587-96. PubMed ID: 10194083 [TBL] [Abstract][Full Text] [Related]
13. Clinical resistance of recurrent Candida albicans vulvovaginitis to fluconazole in the presence and absence of in vitro resistance. MacNeill C; Weisz J; Carey JC J Reprod Med; 2003 Feb; 48(2):63-8. PubMed ID: 12621787 [TBL] [Abstract][Full Text] [Related]
14. Evolution of vaginal Candida species recovered from human immunodeficiency virus-infected women receiving fluconazole prophylaxis: the emergence of Candida glabrata? Terry Beirn Community Programs for Clinical Research in AIDS (CPCRA). Vazquez JA; Sobel JD; Peng G; Steele-Moore L; Schuman P; Holloway W; Neaton JD Clin Infect Dis; 1999 May; 28(5):1025-31. PubMed ID: 10452629 [TBL] [Abstract][Full Text] [Related]
15. [Oesophageal candidiasis: clinical and mycological analysis]. Olmos MA; Araya V; Concetti H; Ramallo J; Piskorz E; Pérez H; Cahn P; Kaufman S; Guelfand L Acta Gastroenterol Latinoam; 2005; 35(4):211-8. PubMed ID: 16496852 [TBL] [Abstract][Full Text] [Related]
16. Reduced fluconazole susceptibility of Candida albicans isolates in women with recurrent vulvovaginal candidiasis: effects of long-term fluconazole therapy. Shahid Z; Sobel JD Diagn Microbiol Infect Dis; 2009 Jul; 64(3):354-6. PubMed ID: 19501794 [TBL] [Abstract][Full Text] [Related]
17. Weekly fluconazole for the prevention of mucosal candidiasis in women with HIV infection. A randomized, double-blind, placebo-controlled trial. Terry Beirn Community Programs for Clinical Research on AIDS. Schuman P; Capps L; Peng G; Vazquez J; el-Sadr W; Goldman AI; Alston B; Besch CL; Vaughn A; Thompson MA; Cobb MN; Kerkering T; Sobel JD Ann Intern Med; 1997 May; 126(9):689-96. PubMed ID: 9139554 [TBL] [Abstract][Full Text] [Related]
18. Significance of isolation and drug susceptibility testing of non-Candida albicans species causing oropharyngeal candidiasis in HIV patients. Nadagir SD; Chunchanur SK; Halesh LH; Yasmeen K; Chandrasekhar MR; Patil BS Southeast Asian J Trop Med Public Health; 2008 May; 39(3):492-5. PubMed ID: 18564689 [TBL] [Abstract][Full Text] [Related]
19. New evidence that Candida albicans possesses additional ATP-binding cassette MDR-like genes: implications for antifungal azole resistance. Walsh TJ; Kasai M; Francesconi A; Landsman D; Chanock SJ J Med Vet Mycol; 1997; 35(2):133-7. PubMed ID: 9147273 [TBL] [Abstract][Full Text] [Related]